Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

Clinical trial NCT01246479 · COMPLETED

Trial details

NCT number: NCT01246479
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Japanese Encephalitis

Start date: 2010-10-01
Primary completion: 2012-10-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.